Synthesis of 2′,3′-dideoxypurinenucleosides via the palladium catalyzed reduction of 9-(2,5-di-O-acetyl-3-bromo-3-deoxy-β-D-xylofuranosyl)purine derivatives

Nucleosides and Nucleotides

Volumn 15, Issue 1-3, 1996, Pages 31-45

  Shiragami, Hiroshi ^a   Amino, Yusuke ^a   Honda, Yutaka ^a   Arai, Masayuki ^a   Tanaka, Yasuhiro ^a   Iwagami, Hisao ^a   Yukawa, Toshihide ^a   Izawa, Kunisuke ^a  

^a AJINOMOTO CO INC   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2',3' DIDEOXYADENOSINE; 2',3' DIDEOXYGUANOSINE; 2',3' DIDEOXYNUCLEOSIDE DERIVATIVE;

ARTICLE; DRUG SYNTHESIS; REACTION ANALYSIS; TECHNIQUE; X RAY CRYSTALLOGRAPHY;

EID: 0029935558     PISSN: 07328311     EISSN: None     Source Type: Journal    
DOI: 10.1080/07328319608002368     Document Type: Article

References (35)

1. Mitsuya, H.; Weinhold, K. J.; Furman, P. A.; St. Clair, M. H.; Lehrman, S. N.; Gallo, R. C.; Bolognesi, D.; Barry, D. W.; Broder, S. Proc. Natl. Acad. Sci. U.S.A. 1985, 82, 7096.
2. (a) Mitsuya, H.; Weinhold, K. J.; Furman, P. A.; St. Clair, M. H.; Lehrman, S. N.; Gallo, R. C.; Bolognesi, D.; Barry, D. W.; Broder, S. Proc. Natl. Acad. Sci. U.S.A. 1985, 82, 7096.
3. (b) Mitsuya, H.; Broder, S. Ibid. 1986, 83, 1911.
4. (c) Dahlberg, J. E.; Mitsuya, H.; Blam, S. B.; Broder, S.; Aaronson, S. A. Ibid. 1987, 84, 2469.
5. (d) Kim, C.; Marquez, V. E.; Broder, S.; Mitsuya, H.; Driscoll, J. S. J. Med. Chem. 1987, 30, 862.
6. (e) Herdewijn, P.; Balzarini, J.; De Clercq, E.; Pauwels, R.; Baba, M; Broder, S. Ibid. 1987, 30, 1270.
7. (a) Coony, D. A.; Dalal, M.; Mitsuya, H.; McMahon, J. B.; Nadkarni, M.; Balzarini, J.; Broder, J.; Johns, D. G.; Biochem. Pharmacol. 1986, 35, 2065.
8. (b) Lin, T. S.; Chen, M. S.; McLaren, C.; Gao, Y. S.; Ghazzouli, I.; Prusoff, W. H. J. Med. Chem, 1987, 30, 440.
9. (a) Broder, S. Med. Res. Rev. 1990, 10, 410.
10. (b) Johnson, V. A.; Barlow, M. A.; Merrill, D. P.; Chou, T-C.; Hirsch, M. S. J. Infect. Dis. 1990, 161, 1059.
11. (c) Dornsife, R. A.; St Clair, M. H.; Huang, A. Averett, D. R. Antimicrob. Agents Chemother. 1990, 35, 322.
12. Human immunodeficiency virus, which causes AIDS. For instance (a) Provic, M; Sarngadharan, M. G.; Read, E.; Gallo, R. C. Science 1984, 224, 497. (b) Broder, S.; Gallo, R. C. Annu. Rev. Immunol. 1985, 3, 321. (c) Wong-Staal, F.; Gallo, R. C. Nature 1985, 317, 395.
13. Human immunodeficiency virus, which causes AIDS. For instance (a) Provic, M; Sarngadharan, M. G.; Read, E.; Gallo, R. C. Science 1984, 224, 497. (b) Broder, S.; Gallo, R. C. Annu. Rev. Immunol. 1985, 3, 321. (c) Wong-Staal, F.; Gallo, R. C. Nature 1985, 317, 395.
14. Human immunodeficiency virus, which causes AIDS. For instance (a) Provic, M; Sarngadharan, M. G.; Read, E.; Gallo, R. C. Science 1984, 224, 497. (b) Broder, S.; Gallo, R. C. Annu. Rev. Immunol. 1985, 3, 321. (c) Wong-Staal, F.; Gallo, R. C. Nature 1985, 317, 395.
15. (a) Robins, M. J.; Hansske, F.; Low, N. H.; Park, J. I. Tetrahedron Lett. 1984, 25, 367.
16. (b) Mansuri, M. M.; Starrett Jr, J. E.; Wos, J. A.; Tortolani, D. R.; Brodfueher, P. R.; Howell, H. G.; Martin, J. C. J. Org. Chem. 1989, 54, 4780.
17. (c) Chu, C. K.; Bhadti, V. S.; Doboszewski, B.; Gu, Z. P.; Kosugi, Y.; Pullaiah, K. C.; Roey, P. V. ibid. 1989, 54, 2217.
18. Kochi, J. K.; Singleton, D. M.; Andrews, L. J. Tetrahedron 1968, 24, 3503.
19. Jain, T. C.; Jenkins, I. D.; Russell, A. F.; Verheyden, J. P. H.; Moffatt, J. G. J. Org. Chem. 1974, 39, 30.
20. Classon, C.; Samuelson, B. Acta. Chimica. Scand. 1982, 251.
21. Amino Y.; and Iwagami, H. Chem. Pharm. Bull, 1991, 39, 622.
22. In reference 6, Kochi et al. mentioned "protolytic reduction" as a simple reduction of a halide with two electrons and one proton.
23. Russel, A. F.; Greenbergs, S.; Moffatt, J. G. J. Amer. Chem. Soc. 1973, 95, 4025.
24. Norman, D. G.; Reese, C. B. Synthesis 1983, 304.
25. Verheiden, J. P. H.; Moffatt, J. G. J. Org. Chem. 1972, 37, 2289.
26. Greenberg, S.; Moffatt, J. G. J. Amer. Chem. Soc. 1973, 95, 4016.
27. Shiragami, H.; Tanaka, Y.; Uchida, Y.; Iwagami, H.; Izawa, K.; Yukawa, T. Nucleosides & Nucleotides 1992, 11, 391.
28. Jain, T. C.; Russel, A. F.; Moffatt, J. G. J. Org. Chem. 1973, 18, 3179.
29. (a) Lee, B.; Luo, W.; Suzuki, S.; Robins, M. J.; Tyrrell, D. L. Antimicrob. Agents Chemother. 1989, 33, 336.
30. (b) Mamber, S. W.; Brookshire, K. W.; Forenza, S. Antimicrob. Agents Chemother. 1990, 34, 1237.
31. (c) Suzuki, S.; Lee, B.; Luo, W.; Tovell, D.; Robins, M. J.; Tyrrell, D. L. J. Biochem. Biophys. Res. Commmun. 1991, 156, 1144.
32. Robins, M. J.; Wilson, J S.; Hansske, F. J. Amer. Chem. Soc. 1983, 105, 4059.
33. Marumoto, R.; Honjo, M. Chem. Pharm. Bull. 1974, 22, 128.
34. Kawashima, E.; Aoyama, Y.; Sekine, T.; Nakamura, E.; Kainosho, M.; Kyogoku, Y.; Ishido, Y. Tetrahedron Lett, 1993, 34, 1317.
35. The selective reduction to produce thymidine from 1-(3,5-di-O-acetyl-2-bromo-2-deoxy-β-D-ribofuranosyl)thymine (12) will be reported later.